Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.27 0.27(1.80%) Jul 29, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.25-0.26-0.800.20
No. of Analysts11.0010.0010.0010.00
Low Estimate-0.29-0.36-1.15-1.05
High Estimate-0.19-0.11-0.412.28
Year Ago EPS-0.14-0.19-0.58-0.80
Revenue EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate90.00K4.88M27.92M141.22M
No. of Analysts11111010
Low EstimateNaNNaN13.70M36.90M
High Estimate400.00K35.40M58.23M263.00M
Year Ago SalesNaNNaN7.00M27.92M
Sales Growth (year/est)N/AN/A298.90%405.80%
Earnings HistoryJun 13Sep 13Dec 13Mar 14
EPS Est-0.10-0.11-0.16-0.08
EPS Actual-0.14-0.19-0.21-0.15
Difference-0.04-0.08-0.05-0.07
Surprise %-40.00%-72.70%-31.20%-87.50%
EPS TrendsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.25-0.26-0.800.20
7 Days Ago-0.25-0.25-0.790.20
30 Days Ago-0.25-0.25-0.790.20
60 Days Ago-0.25-0.25-0.790.20
90 Days Ago-0.21-0.17-0.500.49
EPS RevisionsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0110
Down Last 90 DaysN/AN/AN/AN/A
Growth EstKERXIndustrySectorS&P 500
Current Qtr.-78.60%N/A-63.90%12.10%
Next Qtr.-36.80%N/A-63.30%20.10%
This Year-37.90%N/A100.30%8.20%
Next Year125.00%N/A44.60%12.30%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)30.00%21.81%15.36%9.71%
Price/Earnings (avg. for comparison categories)-19.096.036.837.81
PEG Ratio (avg. for comparison categories)-0.6427.807.721.77
Currency in USD.